Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fedele Bonifazi

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of Personalized Medicine|March 28, 2024
Special Issue "Personalized Medicine in Blood Disease of Children"Adriana Ceci, Petros Kountouris, Antonella Didio, et al.
European Journal of Health Law|March 2, 2021
Machine Learning Systems Applied to Health Data and SystemFedele Bonifazi, Elisabetta Volpe, Giuseppe Digregorio, et al.
British Journal of Clinical Pharmacology|December 21, 2021
Health technology assessment of paediatric medicines: European landscape, challenges and opportunities inside the conect4children projectFrancesco Moretti, Fabrice Ruiz, Fedele Bonifazi, et al.
Frontiers in Medicine|February 14, 2025
Effects of the Paediatric Regulation funding on the development of off-patent medicines in childrenLucia Ruggieri, Silvia Torretta, Viviana Giannuzzi, et al.
Frontiers in Medicine|July 31, 2023
Target therapy for high-risk neuroblastoma treatment: integration of regulatory and scientific tools is neededAdriana Ceci, Rosa Conte, Antonella Didio, et al.
Health Research Policy and Systems|August 6, 2025
Ethical and regulatory requirements for conducting researcher-driven large-scale multinational genetic haematological studies: the INHERENT experienceAntonella Didio, Viviana Giannuzzi, Natasha Archer, et al.
Frontiers in Medicine|February 19, 2021
Paediatric Medicines in Europe: The Paediatric Regulation-Is It Time for Reform?Maddalena Toma, Mariagrazia Felisi, Donato Bonifazi, et al.
Orphanet Journal of Rare Diseases|April 5, 2017
Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: an increased common effort is to be foreseenViviana Giannuzzi, Rosa Conte, Annalisa Landi, et al.
Therapeutic Innovation & Regulatory Science|June 20, 2024
Harmonizing Quality Improvement Metrics Across Global Trial Networks to Advance Paediatric Clinical Trials DeliverySabah Attar, Angie Price, Collin Hovinga, et al.
Pediatric Blood & Cancer|August 30, 2025
Highlighting Healthcare Disparities in Sickle Cell Disease Management in Resource-Constrained Settings: A Cross-Sectional Study in LebanonMorgan Bou Zerdan, Adele Watfa, Bruna Kfoury, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Personalized Medicine|March 28, 2024
Special Issue "Personalized Medicine in Blood Disease of Children"Adriana Ceci, Petros Kountouris, Antonella Didio, et al.
European Journal of Health Law|March 2, 2021
Machine Learning Systems Applied to Health Data and SystemFedele Bonifazi, Elisabetta Volpe, Giuseppe Digregorio, et al.
British Journal of Clinical Pharmacology|December 21, 2021
Health technology assessment of paediatric medicines: European landscape, challenges and opportunities inside the conect4children projectFrancesco Moretti, Fabrice Ruiz, Fedele Bonifazi, et al.
Frontiers in Medicine|February 14, 2025
Effects of the Paediatric Regulation funding on the development of off-patent medicines in childrenLucia Ruggieri, Silvia Torretta, Viviana Giannuzzi, et al.
Frontiers in Medicine|July 31, 2023
Target therapy for high-risk neuroblastoma treatment: integration of regulatory and scientific tools is neededAdriana Ceci, Rosa Conte, Antonella Didio, et al.
Health Research Policy and Systems|August 6, 2025
Ethical and regulatory requirements for conducting researcher-driven large-scale multinational genetic haematological studies: the INHERENT experienceAntonella Didio, Viviana Giannuzzi, Natasha Archer, et al.
Frontiers in Medicine|February 19, 2021
Paediatric Medicines in Europe: The Paediatric Regulation-Is It Time for Reform?Maddalena Toma, Mariagrazia Felisi, Donato Bonifazi, et al.
Orphanet Journal of Rare Diseases|April 5, 2017
Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: an increased common effort is to be foreseenViviana Giannuzzi, Rosa Conte, Annalisa Landi, et al.
Therapeutic Innovation & Regulatory Science|June 20, 2024
Harmonizing Quality Improvement Metrics Across Global Trial Networks to Advance Paediatric Clinical Trials DeliverySabah Attar, Angie Price, Collin Hovinga, et al.
Pediatric Blood & Cancer|August 30, 2025
Highlighting Healthcare Disparities in Sickle Cell Disease Management in Resource-Constrained Settings: A Cross-Sectional Study in LebanonMorgan Bou Zerdan, Adele Watfa, Bruna Kfoury, et al.
Pageof 4